Cnidarian as Useful Invertebrate Model to Explore New Drugs and Nanoformulations
Mariarosaria De Simone a, Angela Tino a, Claudia Tortiglione a, Giuseppina Tommasini a e, Marika Iencharelli a, Federica Sodano b, Maria Grazia Rimoli b, Vincenzo Taresco d, Cameron Alexsander e
a Istituto Scienze Applicate e Sistemi Intelligenti, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy
b Dipartimento di Farmacia , Università degli Studi di Napoli Federico II, Napoli, Italy, Via Giulio Cesare Cortese, 29, 80133 Napoli NA, Italia
c School of Pharmacy, University of Nottingham, UK, Nottingham NG7 2RD, Reino Unido, United Kingdom
d School of Chemistry, University of Nottingham, UK, Nottingham NG7 2RD, Reino Unido, United Kingdom
e Instituto de Nanociencia y Materiales de Aragón INMA, Calle de Pedro Cerbuna, 12, Zaragoza, Spain
Proceedings of Advanced materials and devices for nanomedicine (AMA4MED)
VALÈNCIA, Spain, 2022 May 3rd - 4th
Organizers: Claudia Tortiglione and María Moros
Poster, Angela Tino, 025
Publication date: 22nd April 2022
ePoster: 

The best known and most widespread neurodegenerative illnesses are Alzheimer's (AD) and Parkinson's disease (PD). The conventional treatments developed offer relatively little symptomatic benefit, and remain palliative, consequently the research and development of more powerful and effective pharmacological tools for these diseases are of daily interest. Arundic acid is a new derivative of valproic acid, both are potential drugs for the treatment of AD and PD (Landmark, 2008). Some studies have shown that astrocytes are the primary target of these two agents (Chen et al. 2006, Asano et al. 2005); however, the mechanism by which they carry out their glioprotective action as well as their toxicological profile ­­­­­­­­is not fully defined. In this work, valproic and arundic acids have been tested in two animal models: Hydra vulgaris and Nematostella vectensis. These small polyps are considered excellent model organisms for both in vivo and in vitro studies, in fact they are equipped with a simple anatomical structure and a simple neural system that allows studies of signal transmission. Furthermore, the transparency of the body allows bioimaging studies, to monitoring the localization of fluorescent and / or metal-based nanomaterial. With the aim to identify the toxicological profile and the mechanism of action of arundic and valproic acids, we investigated the morpho-functional response and gene expression. The preliminary data here reported,  are the starting point for chitosan nanoformulation of these drugs, with the purpose of designing new pharmaceutical forms that improve administration and compliance in particular the palatability given that the use of arundic acid in clinical administration has encountered numerous obstacles, related to the difficult administration of this compound and its unpleasant taste.

funding: International Exchanges 2019 Round 2 della Royal Society -London  n° IES\R2\192256

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info